Home›Stock Screener›Arunjyothi Bio Ventures

Arunjyothi Bio Ventures Share Price Today | Stock Price & Arunjyothi Bio Ventures Share Screener

ABVL Other Financial Services
Live Share Price BSE
₹3.92
▼ -0.12 (-2.97%)
2026-10-05 00:00:00

As of October 5, 2026, the live Arunjyothi Bio Ventures share price (BSE: ABVL) is ₹3.92, down 2.97% from the previous close, with shares trading between ₹3.83 and ₹4.00 in today's trading session, and a 52-week range of ₹3.92–₹12.71. Check ABVL annual price range for the annual price range and momentum. Use the Arunjyothi Bio Ventures stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Arunjyothi Bio Ventures opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Arunjyothi Bio Ventures Market Cap ₹73.25 Cr.
ABVL P/E Ratio (TTM) -12.63
Arunjyothi Bio Ventures P/B Ratio 2.62
EPS (TTM) ₹-0.24
Dividend Yield -
Debt to Equity 0.78
ABVL 52 Week High ₹12.71
Arunjyothi Bio Ventures 52 Week Low ₹3.92
Operating Margin 31.00%
Profit Margin -
ABVL Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹54.00
Total Equity ₹29.00

Arunjyothi Bio Ventures Share Price Chart

Track the current stock price of Arunjyothi Bio Ventures with an interactive chart. Analyse ABVL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Arunjyothi Bio Ventures stock quote in one place.

The quote of ₹3.92 sits between the 52-week low of ₹3.92 and the 52-week high of ₹12.71, and the latest session moved -2.97% from the previous close.

Arunjyothi Bio Ventures Company Profile - Fundamental Screener

Screen Arunjyothi Bio Ventures company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ABVL shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Financial Services sector and the Other Financial Services industry, and it trades under ISIN INE485K01022.

Company Details

Classification

Sector Financial Services
Industry Other Financial Services
Sub-Sector Other Financial Services
Segment E

Identifiers and Leadership

ISIN INE485K01022

Arunjyothi Bio Ventures Balance Sheet Screener

Screen ABVL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹54, down from ₹61 in 2025.

Latest statistics put total assets at ₹54 and shareholder funds at ₹29, with a leverage ratio of 0.78.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 54 61 54 36 2 5 6 6 10 20
Current Assets 6 16 11 6 1 3 4 4 9 18
Fixed Assets 46 44 41 0 0 0 0 0 0 0

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 12 16 47 32 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 29 33 2 2 2 2 2 2 2 2
Share Capital 19 19 2 2 2 2 2 2 2 2
Reserves & Surplus 10 15 0 0 0 0 0 0 0 0

Arunjyothi Bio Ventures Income Statement Screener - Profit & Revenue Analysis

Screen Arunjyothi Bio Ventures income statement and profit fundamentals. Analyze ABVL quarterly results. Arunjyothi Bio Ventures reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2010-Dec, revenue was ₹0 and net profit was ₹0, equal to earnings per unit of ₹0.19, at an operating margin of 31%.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2010-Sept, shows revenue of ₹0 and net profit of ₹0.

Item 2010-Dec 2010-Sept

Revenue and Expenses

Revenue 0 0
Expenses 0 0

Operating Costs and Margins

EBITDA 0 0
Operating Profit % 31.00% 38.00%
Depreciation 0 0
Interest 0 0

Profit and Earnings

Profit Before Tax 0 0
Tax 0 0
Net Profit 0 0
EPS 0.19 0.00

Arunjyothi Bio Ventures Cash Flow Screener - Liquidity Fundamentals

Screen ABVL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹10, and net cash flow was an outflow of ₹1.

Over the same period, investing activities used ₹5 and financing activities used ₹6.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 10 2 6 -13 -1 0 1 -3 3 0
Investing Activities -5 -6 -23 -19 0 0 0 0 0 0

Financing and Net Cash

Financing Activities -6 5 16 32 0 0 0 0 0 0
Net Cash Flow -1 1 0 0 -1 0 1 -3 3 0

Arunjyothi Bio Ventures Shareholding Pattern Screener

See Arunjyothi Bio Ventures shareholding pattern with promoter, FII, and DII holdings. Check Arunjyothi Bio Ventures promoter holding and ownership changes for ABVL on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 47.64%, foreign institutions 0.00%, domestic institutions 0.00% and the public 49.04%, spread across 5,634 shareholders.

The shareholder count was 5,634 in 2026-Mar, compared with 20,483 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 47.64% 47.64% 47.64% 47.64% 47.64% 47.64% 48.97% 61.79%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 49.04% 49.15% 49.59% 49.32% 49.08% 49.36% 49.00% 36.45%
Other Holding 3.32% 3.21% 2.78% 3.04% 3.29% 3.01% 2.03% 1.76%
Shareholder Count 5,634 20,483 5,122 5,439 5,321 5,215 740 1,168

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Arunjyothi Bio Ventures. Arunjyothi Bio Ventures dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Arunjyothi Bio Ventures.

Arunjyothi Bio Ventures Stock Index Membership - Nifty & Sensex

See which indices include Arunjyothi Bio Ventures stock. Check ABVL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Arunjyothi Bio Ventures is not part of any tracked indices.
Only major market indices are tracked in our system.

Arunjyothi Bio Ventures Market Events Screener - Corporate Actions

Get Arunjyothi Bio Ventures corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Arunjyothi Bio Ventures stock events that may affect ABVL share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated August 12, 2026, with a record date of August 12, 2026.

It is followed by Quarterly Result Announcement dated July 9, 2026 and Quarterly Result Announcement dated May 13, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-12 2026-08-12 Annual General Meeting NA -10.10%
2026-07-09 2026-07-09 Quarterly Result Announcement NA 2.87%
2026-05-13 2026-05-13 Quarterly Result Announcement NA -14.06%
2026-02-03 2026-02-03 Quarterly Result Announcement NA -0.56%
2025-11-03 2025-11-03 Quarterly Result Announcement NA -7.79%
2025-09-10 2025-09-10 Annual General Meeting NA 26.70%
2025-08-04 2025-08-04 Quarterly Result Announcement NA -3.74%
2025-05-29 2025-05-29 Quarterly Result Announcement NA -4.35%
2025-01-27 2025-01-27 Quarterly Result Announcement NA -8.64%
2025-01-17 2025-01-17 Split 1:10 14.05%
2025-01-06 2025-01-06 Extraordinary General Meeting NA 13.81%
2024-11-12 2024-11-12 Quarterly Result Announcement NA 9.33%
2024-09-14 2024-09-14 Annual General Meeting NA 4.36%
2024-03-12 2024-03-12 Rights 8:1 4.88%
2023-11-27 2023-11-27 Extraordinary General Meeting NA 16.47%

Arunjyothi Bio Ventures Competitors Screener - Peer Stocks Comparison

Screen ABVL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Financial Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
RRP Semiconductor 11,070 -1434.90 -7 -120.94% -8
OnEMI Technology Solutions 6,641 20.82 2,209 63.31% 282 66.10
Colab Platforms 2,597 535.63 163 132.81% 5
Algoquant Fintech 1,920 41.66 236 0.34% 33 49.74
Spice Lounge Food Works 1,848 126.82 162 52.16% 10 41.11
Gyftr 1,203 55.25 380 2540.69% 22 35.07
Prime Securities 1,016 216.78 138 54.36% 14 60.12
Wealth First Portfolio Managers 934 29.29 71 18.30% 38 59.15
RNFI Services 792 24.27 974 5.47% 32 46.72
Stellant Securities 523 37.43 0 % 0 47.36

Arunjyothi Bio Ventures Company Announcements - News & Reports Screener

Screen ABVL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 22, 2026.

The next most recent announcements are dated September 3, 2026 and August 12, 2026.

Date Update Actions
2026-09-22 Closure of Trading Window -
2026-09-03 Announcement under Regulation 30 (LODR)-Change of Company Name -
2026-08-12 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-12 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-07-20 Reg. 34 (1) Annual Report. -
2026-07-20 Notice Of AGM For The FY 2025-26 Scheduled To Be Held On 12.08.2026 -
2026-07-09 Announcement under Regulation 30 (LODR)-Change in Management -
2026-07-09 Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended 30.06.2026. -
2026-07-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-07-04 Board Meeting Intimation for Board Meeting To Be Held On 09.07.2026. -
2026-06-24 Closure of Trading Window -
2026-05-26 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-13 Audited Financial Statements For The Quarter And Year Ended 31.03.2026 -
2026-05-12 Board Meeting Intimation for Postponement Of Board Meeting Scheduled To Be Held On 12.05.2026 To 13.05.2026 -
2026-05-05 Board Meeting Intimation for Postponement Of Board Meeting Scheduled To Be Held On 08.05.2026 To 12.05.2026. -
2026-05-01 Board Meeting Intimation for Board Meeting To Be Held On 08.05.2026. -
2026-04-30 Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 -
2026-04-30 Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A -
2026-04-17 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹3.92, within a 52-week range of ₹3.92 to ₹12.71. The P/E ratio is -12.63 and the P/B ratio is 2.62, with earnings per unit of ₹-0.24. Market capitalisation stands at ₹73.25 Cr. The company operates in the Financial Services sector, in the Other Financial Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 2 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.